Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study

Published:2017-11-15 Issue:2 Volume:27 Page:174-181
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Pottegård Anton¹^ORCID,Grove Erik L.²³,Hellfritzsch Maja¹

Affiliation:

1. Clinical Pharmacology and Pharmacy, Department of Public Health; University of Southern Denmark; Odense Denmark

2. Department of Cardiology; Aarhus University Hospital; Aarhus Denmark

3. Department of of Clinical Medicine, Faculty of Health; Aarhus University; Aarhus Denmark

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.4350/fullpdf

Reference43 articles.

1. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS;Kirchhof;Eur Heart J,2016

2. Non-vitamin K antagonist oral anticoagulants for the prevention of recurrent venous thromboembolism;Bauersachs;Thromb Res,2016

3. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N Engl J Med,2013

4. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism;Hokusai-VTE Investigators;N Engl J Med,2013

5. Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: temporal trends 2011-2015 in Denmark;Staerk;Sci Rep,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of risk factors for adverse drug reactions in a pharmacovigilance database;Pharmacoepidemiology and Drug Safety;2023-08-14

2. Seguridad y efectividad del edoxabán en la práctica clínica tras un año de seguimiento en España. Registro ETNA-AF-EUROPE;REC: CardioClinics;2022-01

3. Utilization and long‐term persistence of direct oral anticoagulants among patients with nonvalvular atrial fibrillation and liver disease;British Journal of Clinical Pharmacology;2021-09-12

4. Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study;Netherlands Heart Journal;2021-01-07

5. Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study;Acta Cardiologica;2021-01-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3